Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
3.380
+0.120 (3.68%)
At close: Aug 14, 2026, 4:00 PM EDT
3.380
0.00 (0.00%)
Pre-market: Aug 17, 2026, 4:39 AM EDT
Jin Medical International Revenue
Jin Medical International had revenue of $8.92M in the half year ending March 31, 2026, a decrease of -15.51%. This brings the company's revenue in the last twelve months to $19.73M, down -13.59% year-over-year. In the fiscal year ending September 30, 2025, Jin Medical International had annual revenue of $20.69M, down -11.98%.
Revenue (ttm)
$19.73M
Revenue Growth
-13.59%
P/S Ratio
1.34
Revenue / Employee
$72,253
Employees
273
Market Cap
26.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 20.69M | -2.81M | -11.98% |
| Sep 30, 2024 | 23.50M | 3.68M | 18.57% |
| Sep 30, 2023 | 19.82M | 630.92K | 3.29% |
| Sep 30, 2022 | 19.19M | -1.57M | -7.58% |
| Sep 30, 2021 | 20.76M | 4.57M | 28.22% |
| Sep 30, 2020 | 16.19M | -4.17M | -20.49% |
| Sep 30, 2019 | 20.37M | -545.02K | -2.61% |
| Sep 30, 2018 | 20.91M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.81M |
| Retractable Technologies | 33.90M |
| Bionano Genomics | 30.18M |
| Precision Optics Corporation | 28.94M |
| Nephros | 20.72M |
| Milestone Scientific | 9.42M |
| Femasys | 2.30M |
| Zentek | 76.23K |
ZJYL News
- 12 days ago - JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results - PRNewsWire
- 4 months ago - Jin Medical regains compliance with Nasdaq’s minimum bid price requirement - TheFly
- 4 months ago - Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement - PRNewsWire
- 5 months ago - Jin Medical International Ltd trading halted, news pending - TheFly
- 5 months ago - Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative - PRNewsWire
- 6 months ago - Jin Medical CEO Fireside Chat - PRNewsWire
- 7 months ago - Jin Medical International Ltd. To Host Management Fireside Chat - PRNewsWire
- 7 months ago - Jin Medical Announces the Official Commencement Date of Chuzhou Facility - PRNewsWire